Alcon rejects Novartis buyout

An independent committee of directors of Alcon Inc. (NYSE:ACL) formally rejected a takeover proposal from Novartis AG (NYSE:NVS; SIX:NOVN) and called the offer "grossly inadequate." Novartis, which al...